Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Transplant: full-pipeline trial registry
4 of 6 indexed Transplant trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Transplant: 6 US clinical trials tracked, 4 recruiting.
Transplant is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is TransMedics, running 1 of these trials.
Enrollment posture brief
Registry condition transplant
OPEN 4 | RECR 67% | LATE 1 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)
Transplant lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Transplant is recruiting above its size-band peers.
4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Transplant research.
TransMedics accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Transplant enrolment sits around 240 participants.
Median target enrolment is 240 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Transplant research leans observational.
2 interventional and 4 observational studies make up this index (33.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
Methodist Health System
NCT04182607
Optimizing Y90 Therapy for Radiation Lobectomy
Northwestern University
NCT04390724
Concomitant Renal and Urinary Bladder Allograft Transplantation
Mayo Clinic
NCT04626167
Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
Indiana University
NCT05717842
OCS Heart Perfusion Post-Approval Registry
TransMedics
NCT05047068
Xofluza-Wearables Feasibility-Study
Children's Hospital of Philadelphia
NCT06161454
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Transplant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Transplant page
6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Transplant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- TransMedics sponsors the most Transplant trials on record, review their full trial history before evaluating a specific study. See TransMedics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Transplant condition card totals 6 registered trials; most-linked intervention OCS Heart System; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.